More than half of patients with treatment-resistant hidradenitis suppurativa achieved a 55% improvement in their disease after initiating golimumab, a tumor necrosis factor inhibitor, according to a ...
Zacks Investment Research on MSN
ABBV gets CHMP nod for Rinvoq in two different autoimmune diseases
AbbVie ABBV announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...
Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...
In this week’s edition of InnovationRx, we look at AbbVie’s new megadeal, an agentic AI startup saving Medicare $2 million a ...
Arizona employers face a reality: health care costs continue to rise driven primarily by pharmaceutical innovation that is ...
AbbVie Inc. agreed to buy Apogee Therapeutics Inc. for $10.9 billion to bolster its anti-inflammatory drug portfolio amid ...
Do-Eun Lee, MD, has been practicing medicine for more than 20 years, and specializes in diabetes, thyroid issues and general endocrinology. She currently has a private practice in Lafayette, CA.
Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s best-selling medication. Mounjaro generated $8.7 billion for Lilly in the first ...
AbbVie (ABBV) shares added ~2% in the premarket on Thursday after the company raised its full-year earnings outlook as its newer immunology drugs, Skyrizi and Rinvoq, offset weakness in its former ...
Evernorth said it estimates that the Delaware location will dispense 1.5 million specialty medications through Accredo and distribute 200,000 orders for medication and supplies through CuraScript.
Two more drug-making giants will officially start selling popular commercial medications on the White House's discounted pharmaceutical site as soon as Monday, CBS News exclusively learned. American ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果